- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01936272
Randomisierte kontrollierte Studie zu Shunt vs. ETV/CPC für PIH bei ugandischen Säuglingen
Neurokognitive Ergebnisse und Veränderungen des Volumens von Gehirn und Rückenmarksflüssigkeit (CSF) nach der Behandlung von postinfektiösem Hydrozephalus (PIH) bei ugandischen Säuglingen durch Shunting versus ETV/CPC
Two treatment options exist for infant patients with hydrocephalus. Most patients are treated with a surgical procedure in which a shunt is inserted into the brain and abdomen. In recent years, however, another treatment has developed called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC).This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This study will evaluate patients in more detail to measure brain growth and development.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
World over, infants with hydrocephalus are mainly treated using a shunt, which is a device made of soft plastic tubing that moves extra fluid from the brain to the abdomen. Surgery is required to insert a shunt into the brain and the abdomen. In recent years, we have developed another treatment called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC). This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This is the most common cause of hydrocephalus in Ugandan babies. This study will evaluate patients in more detail to measure brain growth and development. Children in the study will have special testing to measure developmental progress as well as special imaging to evaluate the progress of their brain growth.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Phase 3
Kontakte und Standorte
Studienorte
-
-
-
Mbale, Uganda
- CURE Children's Hospital Uganda
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Infants less than 180 days (six months) old
- Symptomatic hydrocephalus
- Post-infectious Hydrocephalus based on clinical and CT parameters2
- Must be from the following Ugandan districts: Bugiri, Busia, Iganga, Jinja, Kampala, Kamuli, Kapchorwa, Katakwi, Kumi, Mayuge, Mbale, Mukono, Pallisa, Sironko, Soroti, and Tororo
Exclusion Criteria:
- Any patient with a scalp erosion or infection that would exclude the patient from shunt implantation
- Any patient with ventricular loculations that would normally indicate the use of ventriculoscopy as an adjunct to shunt placement
- Any patient with absence of any visible cortical mantle on the CT
- Patients must be appropriate candidates for either surgical procedure - shunt placement alone or ETV/CPC
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Chhabra Shunt Placement
The shunting arm will comprise a standard frontal approach ventriculoperitoneal shunt using a silastic Chhabra system. |
|
|
Aktiver Komparator: ETV/CPC
The Endoscopic Third Ventriculostomy/Choroid Plexus Cauterization (ETV/CPC) arm will comprise a standard frontal approach with flexible endoscopy. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change of Age-normed Bayley Scales of Infant Development (BSID)-III scores
Zeitfenster: 12 months and 24 months post treatment
|
Neurocognition will be measured using the BSID-III Cognitive Scale. Change will be assessed at 24 months post treatment from baseline score (12 months post treatment). |
12 months and 24 months post treatment
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Brain Volume
Zeitfenster: 12 months, 24 months, 5 years, and 7-10 years post treatment
|
Volume unit of measure is cubic millimeters. Volume is measured using CT scans. |
12 months, 24 months, 5 years, and 7-10 years post treatment
|
|
CSF Volume
Zeitfenster: 12 months, 24 months, 5 years, and 7-10 years post treatment
|
Volume unit of measure is cubic millimeters. Volume is measured using CT scans. |
12 months, 24 months, 5 years, and 7-10 years post treatment
|
|
Vineland Adaptive Behavior Scales
Zeitfenster: 5 years and 7-10 years post treatment
|
The primary purpose of the VABS is to assess the social abilities of school age children. |
5 years and 7-10 years post treatment
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Benjamin C Warf, MD, Boston Children's Hospital
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Harper JR, Cherukuri V, O'Reilly T, Yu M, Mbabazi-Kabachelor E, Mulando R, Sheth KN, Webb AG, Warf BC, Kulkarni AV, Monga V, Schiff SJ. Assessing the utility of low resolution brain imaging: treatment of infant hydrocephalus. Neuroimage Clin. 2021;32:102896. doi: 10.1016/j.nicl.2021.102896. Epub 2021 Nov 23.
- Punchak M, Mbabazi Kabachelor E, Ogwal M, Nalule E, Nalwoga J, Ssenyonga P, Mugamba J, Rattani A, Dewan MC, Kulkarni AV, Schiff SJ, Warf B. The Incidence of Postoperative Seizures Following Treatment of Postinfectious Hydrocephalus in Ugandan Infants: A Post Hoc Comparison of Endoscopic Treatment vs Shunt Placement in a Randomized Controlled Trial. Neurosurgery. 2019 Oct 1;85(4):E714-E721. doi: 10.1093/neuros/nyz122.
- Kulkarni AV, Schiff SJ, Mbabazi-Kabachelor E, Mugamba J, Ssenyonga P, Donnelly R, Levenbach J, Monga V, Peterson M, MacDonald M, Cherukuri V, Warf BC. Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda. N Engl J Med. 2017 Dec 21;377(25):2456-2464. doi: 10.1056/NEJMoa1707568.
- Rattani A, Spencer JC, Agwu CK, Dewan MC, Kabachelor EM, Ssenyonga P, Mugamba J, Schiff SJ, Kulkarni AV, Warf BC. Five-Year Cost-Effectiveness Analysis of Endoscopic Third Ventriculostomy With Choroid Plexus Cauterization Versus Ventriculoperitoneal Shunting in Postinfectious Hydrocephalus in a Low-Income Setting. Neurosurgery. 2026 Sep 18. doi: 10.1227/neu.0000000000004218. Online ahead of print.
- Mukherjee S, Templeton K, Tindimwebwa S, Lin PY, Sutin J, Yu M, Peterson M, Truwit C, Schiff SJ, Monga V. GLAPAL-H: Global, Local, and Parts Aware Learner for Hydrocephalus Infection Diagnosis in Low-Field MRI. IEEE Trans Biomed Eng. 2026 Jan;73(1):139-152. doi: 10.1109/TBME.2025.3578541.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Geschätzt)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- P00002785
- R01HD085853 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
IPD will not be shared with researchers outside of the study team.
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .